Physician profile
Christopher Bloise
NPI 1164165080
$4,497.04
in general payments reported to CMS, 2019-2025
8 companies · $2,154 in 2025
The $2,154 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $203 · 2023: $515 · 2024: $1,625 · 2025: $2,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,677 · Travel and Lodging: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,677.14 |
| Travel and Lodging | $617.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,535.00 | 2022-2025 | Insignia, Mako, Triathlon |
| Bioventus LLC | $354.94 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $191.50 | 2022-2024 | Cd Horizon Spinal System |
| Alon Medical Technology | $191.44 | 2024 | |
| Linvatec Corporation | $96.85 | 2025 | Biobrace 23mm |
| Vertex Pharmaceuticals Incorporated | $58.34 | 2025 | |
| Convatec INC. | $37.10 | 2025 | |
| Si-Bone, INC. | $31.87 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bloise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.